Informatie:
Fout:
ID
20583
Beschrijving
Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study); ODM derived from: https://clinicaltrials.gov/show/NCT00790946
Link
https://clinicaltrials.gov/show/NCT00790946
Trefwoorden
Versies (1)
- 04-03-17 04-03-17 -
Geüploaded op
4 maart 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hypertension NCT00790946
Eligibility Hypertension NCT00790946
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT00790946
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
gender, hypertension
Item
out patients with hypertension male and female
boolean
C0079399 (UMLS CUI [1])
C0020538 (UMLS CUI [2])
C0020538 (UMLS CUI [2])
systolic pressure, diastolic blood pressure
Item
systolic blood pressure (sbp)≧140mmhg and/or diastolic blood pressure (dbp)≧90 mmhg
boolean
C0871470 (UMLS CUI [1])
C0428883 (UMLS CUI [2])
C0428883 (UMLS CUI [2])
waist surrounding diameter
Item
waist surrounding diameter male≧85cm female≧90cm
boolean
C0455829 (UMLS CUI [1])
Hypertriglyceridemia | Decreased HDL cholesterol | Diabetes Mellitus | Therapeutic procedure
Item
patient who is treating either high triglyceride,low hdl,or diabetes mellitus
boolean
C0020557 (UMLS CUI [1])
C0151691 (UMLS CUI [2])
C0011849 (UMLS CUI [3])
C0087111 (UMLS CUI [4])
C0151691 (UMLS CUI [2])
C0011849 (UMLS CUI [3])
C0087111 (UMLS CUI [4])
Triglycerides measurement | Serum HDL cholesterol measurement | Fasting blood glucose measurement
Item
patient who is untreatment high triglyceride blood syndrome and low hdl blood syndrome,diabetes mellitus is triglceride≧150mg/dl and/or hdl cholesterol < 40 mg/dl or fasting blood glucose ≧110 mg/dl
boolean
C0202236 (UMLS CUI [1])
C0428472 (UMLS CUI [2])
C0428568 (UMLS CUI [3])
C0428472 (UMLS CUI [2])
C0428568 (UMLS CUI [3])
Hypertensive disease; Did not receive therapy or drug for | Hypertensive disease; Antihypertensive Agents | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist
Item
untreated patients with hypertension,or patients is treated with antihypertensive agents except for ace-i and arb
boolean
C0020538 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0020538 (UMLS CUI [2,1])
C0003364 (UMLS CUI [2,2])
C0003015 (UMLS CUI [3])
C0521942 (UMLS CUI [4])
C0332155 (UMLS CUI [1,2])
C0020538 (UMLS CUI [2,1])
C0003364 (UMLS CUI [2,2])
C0003015 (UMLS CUI [3])
C0521942 (UMLS CUI [4])
patient who is using ace-i and arb
Item
patient who is using ace-i and arb
boolean
C0003015 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
C0521942 (UMLS CUI [2])
creatinine
Item
serum creatinine ≧ 3 mg/dl
boolean
C0201976 (UMLS CUI [1])
liver impairment
Item
liver impairment
boolean
C0023895 (UMLS CUI [1])
hypersensitivity valsartan
Item
history of allergy to valsartan
boolean
C0020517 (UMLS CUI [1,1])
C0216784 (UMLS CUI [1,2])
C0216784 (UMLS CUI [1,2])
pregnancy
Item
pregnant women
boolean
C0032961 (UMLS CUI [1])
Physician consent obtained
Item
judgment by the physician that participation was unwise on the basis of patient characteristics and drug safety
boolean
C1320725 (UMLS CUI [1])